Securities Class Action

No Litigation found for Tenaya Therapeutics, Inc.

Material Events

Critical Governance & Disclosure

6

Board, Voting & Shareholder Rights

5

Capital Structure & Financial Risk

1

Disclosure & Communications

11

SEC Filings

Form 4

Statement of changes in beneficial ownership of securities

2026-11-18

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-11-18

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
8-K

Current report

2026-11-04

View 8-K Current report on SEC.gov
DEF 14A

Other definitive proxy statements

2026-10-23

View DEF 14A Other definitive proxy statements on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-10-23

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov

Insider Transaction

Transactions

2

Insider Involved

2

Total Buys

$0.00

Total Sells

$2.16K